REZOLUTE, INC. Property, Plant and Equipment
REZOLUTE, INC. (RZLT) had Property, Plant and Equipment of $41.00 thousand as of 2026-06-30, per its 10-K filed 2026-09-24.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-09-24
- 2026-06-30: Property, Plant and Equipment, Net $41.00K.
- 2026-03-31: Property, Plant and Equipment, Net $49.00K.
- 2025-12-31: Property, Plant and Equipment, Net $57.00K.
- 2025-09-30: Property, Plant and Equipment, Net $64.00K.
| Period end | Property, Plant and Equipment, Net | Property, Plant and Equipment, Net as first filed |
|---|---|---|
| 2026-06-30 | $41.00K 10-K · filed 2026-09-24 | |
| 2026-03-31 | $49.00K 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $57.00K 10-Q · filed 2026-02-12 | |
| 2025-09-30 | $64.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $72.00K 10-K · filed 2026-09-24 | |
| 2025-03-31 | $80.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $87.00K 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $95.00K 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $103.00K 10-K · filed 2025-09-17 | |
| 2024-03-31 | $110.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $119.00K 10-Q · filed 2024-02-13 | |
| 2023-09-30 | $129.00K 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $139.00K 10-K · filed 2024-09-19 | |
| 2023-03-31 | $149.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $160.00K 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $83.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $16.00K 10-K · filed 2023-09-14 | |
| 2022-03-31 | $19.00K 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $22.00K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $26.00K 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $29.00K 10-K · filed 2022-09-15 | |
| 2021-03-31 | $33.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $36.00K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $30.00K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $33.00K 10-K · filed 2021-09-15 | |
| 2020-03-31 | $35.00K 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $38.00K 10-Q · filed 2020-02-12 | |
| 2019-09-30 | $41.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $44.00K 10-K · filed 2020-10-13 | |
| 2019-03-31 | $40.10K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $0.00 10-Q · filed 2019-02-14 | |
| 2018-09-30 | $178.72K 10-Q · filed 2018-12-14 | |
| 2018-06-30 | $368.00K 10-K · filed 2019-09-10 | $368.37K 10-K · filed 2018-10-15 |
| 2018-03-31 | $4.53M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $4.80M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $5.06M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $5.33M 10-K · filed 2018-10-15 | |
| 2017-03-31 | $5.46M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $5.73M 10-Q · filed 2017-02-02 | |
| 2016-09-30 | $5.90M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.98M 10-K · filed 2017-09-22 | |
| 2016-03-31 | $6.13M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $6.07M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | $5.50M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $4.52M 10-K · filed 2016-09-28 | |
| 2015-03-31 | $2.30M 10-Q · filed 2015-05-15 | |
| 2014-12-31 | $1.18M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $812.18K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $337.93K 10-K · filed 2015-09-28 | |
| 2013-06-30 | $275.72K 10-K · filed 2014-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |